MANISH DESAI to Leukotriene B4
This is a "connection" page, showing publications MANISH DESAI has written about Leukotriene B4.
Connection Strength
0.056
-
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Clin Infect Dis. 2023 07 26; 77(2):186-193.
Score: 0.056